Vivo Opportunity, LLC's Net Worth
$573 Million
Who is Vivo Opportunity, LLC?
Vivo Opportunity, LLC has an estimated net worth of $573 Million. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., Crinetics Pharmaceuticals, Inc., SOLENO THERAPEUTICS INC, Terns Pharmaceuticals, Inc., IO Biotech, Inc., ALX ONCOLOGY HOLDINGS INC, Kadmon Holdings, Inc., and Bolt Biotherapeutics, Inc..
SEC CIK
Vivo Opportunity, LLC's CIK is 0001728970
Past Insider Trading and Trends
2021 was Vivo Opportunity, LLC's most active year for acquiring shares with 19 total transactions. Vivo Opportunity, LLC's most active month to acquire stocks was the month of January. 2020 was Vivo Opportunity, LLC's most active year for disposing of shares, totalling 25 transactions. Vivo Opportunity, LLC's most active month to dispose stocks was the month of January. 2022 saw Vivo Opportunity, LLC paying a total of $47,954,257.80 for 6,895,296 shares, this is the most they've acquired in one year. In 2022 Vivo Opportunity, LLC cashed out on 7,041,258 shares for a total of $207,620,683.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $37.74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.02% | -528.00 |
$19.50 | -$10,296.00 | 3.27M |
Mar 9
| |||
Form 4
| -0.21% | -13.46K |
$21.70 | -$291,587.00 | 6.54M |
Feb 7 - Feb 10
| |||
Form 4
| -0.41% | -13.46K |
$22.80 | -$306,888.00 | 3.28M |
Feb 4
| |||
Form 4
| -0.27% | -26.92K |
$22.00 | -$594,164.00 | 9.9M |
Jan 29 - Jan 31
| |||
Form 4
| -11.16% | -417.00K |
$22.25 | -$9,278,250.00 | 3.32M |
Mar 20
| |||
Form 4
| +59.34% | 3.74M |
$17.65 | $6,575,421.40 | 10.04M |
Jul 20
| |||
No matching records found |
Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $5.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.32% | -420.66K |
$6.65 | -$2,796,859.03 | 6.24M |
Scheduled
|
Apr 1 - Apr 3
| ||
Form 4
| +21.18% | 758.62K |
$7.25 | $5,499,995.00 | 4.34M |
Dec 23
| |||
Form 4
| +20.12% | 600K |
$3.60 | $2,160,000.00 | 3.58M |
Sep 7
| |||
Form 4
| +142.80% | 2.62M |
$2.70 | $6,980,244.40 | 4.46M |
Aug 12 - Aug 16
| |||
Form 4
|
∞
| 2.68M |
$17.00 | $6,075,001.00 | 2.68M |
Feb 9
| |||
No matching records found |
Kadmon Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Bolt Biotherapeutics, Inc. (BOLT) Snapshot price: $1.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.15% | -3.40K |
$0.90 | -$3,060.00 | 2.33M |
Nov 21
| |||
Form 4
| -1.35% | -86.05K |
$0.93 | -$79,933.22 | 6.31M |
Nov 16 - Nov 20
| |||
Form 4
| +8,933.46% | 3.83M |
$16.57 | $2,995,480.00 | 3.87M |
Feb 9
| |||
No matching records found |
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.33M |
$55.00 | -$183,123,160.00 |
0
|
Jul 1
| |||
Form 4
| +41.33% | 800K |
$27.00 | $21,600,000.00 | 2.74M |
Jan 31
| |||
Form 4
| +31.95% | 612.44K |
$13.20 | $8,084,168.40 | 2.53M |
Jan 26
| |||
Form 4
| +3,045.01% | 1.86M |
—
|
—
| 1.92M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |